Helping broken bones heal by boosting Notch signaling
Notch signaling and Bone Fracture Healing
Researchers aim to boost a natural cell signal called Notch to help people with large or slow-healing bone fractures recover faster.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-11259514 on NIH RePORTER |
What this research studies
This project looks at how turning up Notch signaling affects the cells and blood vessels that rebuild bone after a break. The team will map which Notch receptors and ligands are active during healing and which specific cell types use them. They will test approaches that increase Notch activity in preclinical bone injury models to see if callus formation and vascular growth improve. The work is intended to move promising findings toward treatments that could be used in people.
Who could benefit from this research
Good fit: People with large bone defects, fractures that are slow to heal, or non-unions would be the most likely candidates for therapies developed from this work.
Not a fit: Patients with small, uncomplicated fractures that are expected to heal normally, or conditions unrelated to bone repair, are unlikely to need or benefit from these therapies.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that speed bone repair, reduce non-unions, and lower the need for grafts or repeat surgeries.
How similar studies have performed: Animal and lab studies have shown that increasing Notch signaling can improve bone regeneration, but translation to human therapies remains limited.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Kalajzic, Ivo — University of Connecticut Sch of Med/dnt
- Study coordinator: Kalajzic, Ivo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.